We tested the hypothesis that alternate-day fasting, without concomitant weight loss, would increase the β-cell secretory capacity in patients with type 2 diabetes, and the data show that ADF alone (albeit with a ∼1% weight loss) does not significantly change insulin secretion in response to an IVGTT. Here, INS is linked to type 2 diabetes mellitus.